AR and ovarian carcinoma: Research involving prostate and ovarian cancer propose the potential role of androgen receptor-coregulators, especially ARA70 (androgen receptor-associated protein 70), which seems to be necessary for both androgen receptor (AR) and VDR transcriptional activity.